IRENs, Billion

IREN's $13 Billion Contract Backlog Can't Shield It From a 35% Monthly Rout

Published on 07/05/2026 at 16:57 | Redaktion boerse-global.de

Despite a brutal 35% monthly sell-off, IREN's $13B contract pipeline with Microsoft and Nvidia, along with heavy short interest, sets the stage for a possible sharp reversal.

IREN Stock Plunges 35% in a Month but $13B Contract Backlog Signals Reversal Potential
IREN's $13 Billion Contract Backlog Can't Shield It From a 35% Monthly Rout Illustration mit AI erstellt übermittelt durch boerse-global.de

A single green session on Friday, with shares jumping 7.01% to €36.35, did little to mask the brutal reality for IREN over the past month. The AI infrastructure play has lost 35.62% of its value in 30 days, caught between a punishing technical sell-off and a growing conviction on Wall Street that the "neocloud" trio is no longer rising together. Yet beneath the surface, a massive contract backlog worth more than $13 billion tells a different story — one that could spark a violent reversal if market sentiment turns.

Analysts remain divided on the severity of the damage. Bernstein's Gautam Chhugani, while acknowledging that IREN trails rivals CoreWeave and Nebius in revenue per megawatt and enterprise scaling, still maintains a buy rating with a $100 price target. The broader consensus on the Street is also bullish, with the average target sitting near $80 — implying substantial upside from current levels. Jefferies has even initiated coverage with a buy recommendation, calling IREN's business-model transformation a compelling strategic pivot. But the critique from Bernstein marks a clear shift in tone for a stock that once rode the AI wave unchallenged.

Technically, the charts offer little comfort. The stock now trades 22.22% below its 50-day moving average of €46.74 and 13.26% beneath the 200-day line at €41.91. At 47.01% off its 52-week high of €68.61 hit on November 3, 2025, the decline has been severe enough to force momentum funds to unwind positions. The 14-day relative strength index sits at 35.2, flirting with oversold territory without confirming it, while annualized 30-day volatility has soared to 93.43%, reflecting extreme swings in investor sentiment.

Should investors sell immediately? Or is it worth buying IREN?

That technical weakness masks a fundamental story that is anything but broken. IREN has secured a $9.7 billion deal with Microsoft and a $3.4 billion cloud agreement with Nvidia, together forming a $13.1 billion contract pipeline that underpins its growth narrative. The company was also added to the Russell 1000 Index this year, triggering a wave of passive buying that has done little to shield the stock from the recent downdraft. Meanwhile, short sellers have piled in: over 64 million shares are now sold short, representing roughly 19% of the float. If the stock manages to reclaim its long-term moving averages in the coming week, the setup for a short squeeze is textbook.

Zooming out, the damage looks far less catastrophic. IREN is essentially flat year-to-date at minus 0.32% and still holds a 152.75% gain over the past twelve months. A sharp monthly pullback barely dents a stock that has nearly trebled in a year. The key technical level to watch is the €42 zone, where the 100- and 200-day moving averages converge. A move back above that area would signal the downtrend is easing. A break below the 52-week low of €13.31 remains a distant but symbolically ominous worst-case scenario.

The market is now asking a simple question: Is IREN a laggard in a fast-moving sector, or is it simply executing a less visible growth story that will eventually catch up with its peers? The answer will shape not just the stock's trajectory but the broader reordering of AI infrastructure valuations. For now, the clash between a $13 billion contract book and a 35% monthly rout creates an unusually wide gap between fundamentals and price — one that rarely stays that way for long.

Ad

IREN Stock: New Analysis - 5 July

Fresh IREN information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IREN analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | AU0000185993 | IRENS | boerse | 69698022 |